Exicure (XCUR) Debt Ratio (2016 - 2024)

Exicure's (XCUR) quarterly Debt Ratio came in at 0.09 in Q2 2024, down 11.69% on a QoQ basis from 0.11 in Q4 2021.

Exicure (XCUR) Debt Ratio (2016 - 2024) Analysis & Trends

Exicure (XCUR) has 7 years of Debt Ratio data on file, last reported at 0.09 in Q2 2024.

Quarterly Debt Ratio changed N/A year-over-year to 0.09 in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 0.09 (changed N/A YoY) and the FY2021 annual result came in at 0.11, down 35.85% from the prior year.
Debt Ratio slipped to 0.09 in Q2 2024, from 0.11 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.22 in Q2 2021 to a low of 0.09 in Q2 2024.
A 3-year average of 0.16 and a median of 0.17 in 2020 frame the typical range for Debt Ratio.
Annual changes were most pronounced in 2020 — Debt Ratio surged 283.41% — and 2021, when it sank 35.85%.
Tracing XCUR's Debt Ratio over 3 years: stood at 0.17 in 2020, then slumped by 35.85% to 0.11 in 2021, then slipped by 11.69% to 0.09 in 2024.
The last three Debt Ratio figures came in at 0.09 (Q2 2024), 0.11 (Q4 2021), and 0.22 (Q3 2021), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.05
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.03
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.26
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.47
10	Exicure	7.27 Mn	7.27 Mn	-	0.11

Download Data